A phase I-II study of gemcitabine and docetaxel in advanced pancreatic cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples